Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.600
-0.030 (-1.14%)
At close: Apr 1, 2025, 4:00 PM
2.500
-0.100 (-3.85%)
After-hours: Apr 1, 2025, 4:16 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.35 million as of April 1, 2025. Its market cap has increased by 194.73% in one year.
Market Cap
2.35M
Enterprise Value
-4.12M
1-Year Change
194.73%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $2.35M, a decrease of -97.40%. That is a compound annual growth rate of -56.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.38M | -38.20% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.48% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.83M | -28.42% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |